Best GLP-1 Providers That Ship to California
Meta title: Best GLP-1 Providers That Ship to California | RangeYourself
Meta description: Compare GLP-1 telehealth programs for California residents by medication pathway, starting price, and support model.
Affiliate Disclosure
RangeYourself may earn commissions through Katalys, Awin, CJ Affiliate, and Amazon Associates.
Ranked Providers
| Rank | Provider | Starting price language | Best for | CTA |
|---|---|---|---|---|
| 1 | ShedRx | From $199/mo | Direct cash-pay GLP-1 shoppers | /go/shedrx |
| 2 | Found | From $99/mo membership; medication may be separate | Structured support | /go/found |
| 3 | Sesame Care | Visit pricing varies; medication may be separate | California telehealth visit | /go/sesame-care |
| 4 | Mochi Health | From $79/mo membership; medication may be separate | Ongoing program support | /go/mochi-health |
| 5 | PlushCare | Pricing varies by visits/membership | Doctor-led care | /go/plushcare |
| 6 | Hims / Hers | Pricing varies by plan | Familiar DTC telehealth | /go/hims |
California Buyer Checklist
Before enrolling, verify:
- California service availability
- Clinician licensing and intake process
- Medication type
- Pharmacy source
- Shipping eligibility
- Total monthly cost
- Side-effect and refill support
Top Pick
ShedRx is a strong starting point for direct cash-pay comparison. Found is better if you want structured support, while Sesame Care and PlushCare are useful for clinician-led conversations.
FAQ
Can California residents get GLP-1 medications online?
Many California residents can access GLP-1 telehealth evaluation if the provider serves the state and a licensed clinician determines eligibility.
Do GLP-1 providers ship to California?
Some do, depending on medication type, pharmacy, provider network, and current availability. Verify before enrolling.
Are compounded GLP-1s available in California?
Availability depends on provider, pharmacy, and current rules. Compounded GLP-1 medications are not FDA-approved finished products.
The FDA has proposed excluding semaglutide and liraglutide from the 503B bulk compounding list, with public comments open through June 29, 2026. If finalized, this could affect the availability, pricing, and continuity of some compounded GLP-1 programs. We will update this page as the regulatory situation develops.
RangeYourself is reader-supported. We may earn a commission when you click on certain links — at no extra cost to you. Editorial recommendations are made independently. Last reviewed May 20, 2026.
